Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001499 · ClinicalTrials.gov registry record · Phase 2

Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

A Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms, sponsored by National Cancer Institute (NCI).

Completed
Registry status
Phase 2
Development phase
50
Enrollment target
1
Study location

NCT00001499: Completed Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms, sponsored by National Cancer Institute (NCI).

NCT00001499 is a Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 50 participants, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00001499, a Phase 2 study of Carcinoma, Non-Small Cell Lung and Lung Neoplasms, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
Phase 2
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

2-Drug Combination Chemotherapy Followed by Radiotherapy. Paclitaxel, TAX, NSC-125973; Cisplatin, CDDP, NSC-119875; followed by chest irradiation using 4-15 MV photons.

Conditions Studied

Carcinoma, Non-Small Cell Lung Lung Neoplasms

Interventions

  • DRUG cisplatin
  • DRUG paclitaxel
  • PROCEDURE chest radiotherapy

Study Locations (1)

Maryland

  • National Cancer Institute (NCI) - Bethesda

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 1996-03
Est. Completion 2000-06
Phase Phase 2
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00001499 record still lists

NCT00001499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 3 interventions - of which cisplatin is the first listed.

NCT00001499 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001499 about?

NCT00001499 is a clinical study titled "Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer". 2-Drug Combination Chemotherapy Followed by Radiotherapy. Paclitaxel, TAX, NSC-125973; Cisplatin, CDDP, NSC-119875; followed by chest irradiation using 4-15 MV photons.

What is the current status of trial NCT00001499?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1996-03. Estimated completion is 2000-06.

What conditions does trial NCT00001499 study?

This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung, Lung Neoplasms.

What interventions are being tested in trial NCT00001499?

The interventions under investigation include: cisplatin (DRUG), paclitaxel (DRUG), chest radiotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT00001499?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001499 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Non-Small Cell Lung

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001499's enrollment target sits among peer trials

50 93rd of 130 higher than 37 of 130 other Carcinoma, Non-Small Cell Lung trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carcinoma, Non-Small Cell Lung trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00001499, the US trial registry maintained by the National Library of Medicine. NCT00001499 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.